Subscribers were alerted to this stock this morning and it traded up nicely. The good news is, it's expected to go higher in the coming days given it's important forward looking news event and undervalued price.

They have a great looking chart and some upcoming news events that will likely see it trading higher in the coming days- especially one that involves the submission of an NDA (new drug application) before the end of the year and two late stage programs that are promising high-return on investment.

ADVENTRX Pharmaceuticals, Inc.

(AMEX:ANX)

Cick to Open Chart

As always, do your own DD. This is an AMEX stock that trades before and after market hours.

Disclosure: long ANX

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

---

Add this page to your favorite Social Bookmarking websites